CO5690615A2 - Composicion nutricional contra efectos colaterales de la quimioterapia o la radioterapia - Google Patents

Composicion nutricional contra efectos colaterales de la quimioterapia o la radioterapia

Info

Publication number
CO5690615A2
CO5690615A2 CO06044896A CO06044896A CO5690615A2 CO 5690615 A2 CO5690615 A2 CO 5690615A2 CO 06044896 A CO06044896 A CO 06044896A CO 06044896 A CO06044896 A CO 06044896A CO 5690615 A2 CO5690615 A2 CO 5690615A2
Authority
CO
Colombia
Prior art keywords
radiotherapy
chemotherapy
nutritional composition
composition
composition against
Prior art date
Application number
CO06044896A
Other languages
English (en)
Inventor
Eduardo Schiffrin
Denis Breuille
Stephanie Blum-Sperise
Anne Donnet-Hughes
Magali Faure
Claudia Roessle
Marco Enrico Turini
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CO5690615A2 publication Critical patent/CO5690615A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Abstract

1.- Una composición nutricional que comprende una proteína, un lípido y una fuente de carbohidratos, cuya composición tiene un contenido de energía de por lo menos 1,3 kcal por ml, en donde la fuente de proteína:proporciona desde 20 a 30% de la energía de la composición;comprende 40 a 80% en peso de caseína y desde 60-20% en peso de suero;comprende desde 0,5 a 20µg de TGF-ß por 100 kcal de la composición; ycomprende glutamina libre en una cantidad en forma tal que provee desde 2 a 15% de la energía de la composición.
CO06044896A 2003-10-16 2006-05-11 Composicion nutricional contra efectos colaterales de la quimioterapia o la radioterapia CO5690615A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03023383 2003-10-16

Publications (1)

Publication Number Publication Date
CO5690615A2 true CO5690615A2 (es) 2006-10-31

Family

ID=34354470

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06044896A CO5690615A2 (es) 2003-10-16 2006-05-11 Composicion nutricional contra efectos colaterales de la quimioterapia o la radioterapia

Country Status (14)

Country Link
US (1) US7468193B2 (es)
EP (1) EP1675480B1 (es)
JP (2) JP5473190B2 (es)
CN (1) CN1889856B (es)
AR (1) AR046184A1 (es)
BR (1) BRPI0415480B1 (es)
CA (1) CA2542652C (es)
CO (1) CO5690615A2 (es)
ES (1) ES2677868T3 (es)
IL (1) IL175081A0 (es)
MY (1) MY148289A (es)
TW (1) TW200526134A (es)
WO (1) WO2005039318A1 (es)
ZA (1) ZA200603886B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1638418E (pt) 2003-06-23 2012-09-20 Nestec Sa Suplementação de aminoácidos para um ecossistema de flora microbiana saudável
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
BRPI0718384A2 (pt) * 2006-10-19 2013-11-12 Nestec Sa Alimentação a longo prazo para pacientes com câncer
CN103494196A (zh) * 2006-10-19 2014-01-08 雀巢产品技术援助有限公司 老年人的长期喂养
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
EP2687106B1 (en) * 2007-12-05 2018-05-02 N.V. Nutricia High energy liquid enteral nutritional composition
US9107867B2 (en) 2008-02-07 2015-08-18 Nestec Sa Compositions and methods for influencing recovery from strenuous physical activity
CN102164595A (zh) * 2008-09-19 2011-08-24 雀巢产品技术援助有限公司 抗癌治疗中的免疫系统营养支持
EP2687209A1 (en) * 2008-09-19 2014-01-22 Nestec S.A. Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
JP2011201842A (ja) * 2010-03-26 2011-10-13 Kobayashi Pharmaceutical Co Ltd 腸由来細胞の増殖促進剤
US9084944B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
PT2611529T (pt) 2010-09-03 2019-05-09 Bend Res Inc Método de secagem por pulverização
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
CN103415295A (zh) * 2010-12-29 2013-11-27 雀巢产品技术援助有限公司 用于减少与压力相关的肠症状的纤维和益生菌
JP5824509B2 (ja) * 2011-03-04 2015-11-25 キユーピー株式会社 経腸栄養剤
WO2012141575A1 (en) 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
US8765201B2 (en) * 2011-06-08 2014-07-01 Creneau Creations, Inc. High calorie food product and method
RU2630299C2 (ru) 2011-06-20 2017-09-06 Г.Дж. Хайнц Компани Брэндс ЛЛК Композиции, способ и наборы для стимулирования мукозальной иммунной системы
FR2979241B1 (fr) * 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
US9693958B2 (en) 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
RU2018129984A (ru) 2013-05-10 2019-03-15 Эйч. Джей. ХАЙНЦ КОМПАНИ БРЕНДС ЛЛСи Пробиотики и способы их применения
US20210169104A1 (en) * 2014-08-11 2021-06-10 Six Sigma Laboratories Llc Oral rehydration composition
CA2962719A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
US11234949B2 (en) 2015-05-14 2022-02-01 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
TWI775921B (zh) 2017-08-14 2022-09-01 美商胺細拉健康公司 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
US5824297A (en) 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
EP0527283B1 (en) * 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Food composition
EP0818529B1 (fr) 1996-07-09 2005-06-22 Societe Des Produits Nestle S.A. Procédé de séchage par pulvérisation
DE29724816U1 (de) 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
CA2223198A1 (en) 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
JP2001128615A (ja) * 1999-11-04 2001-05-15 Ajinomoto Co Inc 乳幼児用調整粉乳
FR2802212B1 (fr) 1999-12-13 2002-03-01 Agronomique Inst Nat Rech Procede pour l'obtention d'une poudre contenant des micro-organismes viables, poudre obtenue selon ce procede et dispositif pour sa mise en oeuvre
WO2002013438A2 (en) * 2000-08-07 2002-02-14 Discovery Life (Pty) Ltd. Managing a life insurance investment
MXPA03004546A (es) * 2000-11-22 2003-09-10 Rxkinetix Inc Tratamiento de mucositis.
ATE361678T1 (de) * 2000-12-27 2007-06-15 Nutricia Nv Ernährungszusammensetzung mit gesundheitsfördernder wirkung enthaltend oligosaccharide
ATE427037T1 (de) 2001-02-19 2009-04-15 Nestle Sa Essbares produkt enthaltend probiotische kulturen
CA2444470A1 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
WO2002085402A1 (en) * 2001-04-24 2002-10-31 The General Hospital Corporation Methods and compositions for treating oral and eosophageal lesions
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients

Also Published As

Publication number Publication date
CA2542652C (en) 2014-05-13
BRPI0415480A (pt) 2006-12-26
CN1889856A (zh) 2007-01-03
CN1889856B (zh) 2011-03-02
EP1675480B1 (en) 2018-06-13
ZA200603886B (en) 2007-11-28
MY148289A (en) 2013-03-29
US20070042021A1 (en) 2007-02-22
BRPI0415480B1 (pt) 2019-09-17
EP1675480A1 (en) 2006-07-05
ES2677868T3 (es) 2018-08-07
JP2012211139A (ja) 2012-11-01
CA2542652A1 (en) 2005-05-06
AR046184A1 (es) 2005-11-30
WO2005039318A1 (en) 2005-05-06
US7468193B2 (en) 2008-12-23
JP2007508343A (ja) 2007-04-05
JP5473190B2 (ja) 2014-04-16
TW200526134A (en) 2005-08-16
IL175081A0 (en) 2006-08-20

Similar Documents

Publication Publication Date Title
CO5690615A2 (es) Composicion nutricional contra efectos colaterales de la quimioterapia o la radioterapia
CO5540276A2 (es) Suplemento liquido oral caloricamente denso
AR037909A1 (es) Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina
MA40801A1 (fr) Anticorps anti-cd3, anticorps anti-cd123 et anticorps bispécifiques se liant spécifiquement à cd3 et/ou cd123
TW200515187A (en) System and method for a unified composition engine in a graphics processing system
NO20024586D0 (no) Metode og preparater for å forhindre hormoninduserte bivirkninger
ATE530577T1 (de) Epha2 agonistische monoklonale antikörper und deren anwendungsverfahren
BR0106674A (pt) Composição primária que contém um composto bioativo lipofìlico
WO2001082932A3 (en) Methods and compositions for enhancing cellular function through protection of tissue components
BRPI0515316A (pt) compostos de imidazoquinolina
TW200621804A (en) Ctla-4 antibody and aromatase inhibitor combination treatment for breast cancer
CO5221085A1 (es) Mejoramiento de la condicion de mascotas anosas
MY158845A (en) Induced-viscosity nutritional emulsions
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
BR0207699A (pt) Produto para aplicação axilar
MXPA05008261A (es) Sistemas estabilizados coloidales y parecidos a coloidales.
BR0009728A (pt) Métodos para estabilização de produtos lìquidos nutricionais e produtos assim estabilizados
FR2801218B1 (fr) Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
HK1092701A1 (en) Heterocarpin, a plant-derived protein with anti-cancer properties
EP1364657A4 (en) REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES
IT1304183B1 (it) Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
EP1682565A4 (en) IAP NUCLEOBASE OLIGOMERS AND OLIGOMERE COMPLEXES AND APPLICATIONS THEREOF
AR058621A1 (es) Metodods para reducir la proteina c reactiva
BRPI0411712A (pt) método para restabelecer a função da tireóide a um estado mais próximo do normal em um felino que sofre de hipertireoidismo, e, composição com iodo reduzido embalada para dieta de felinos

Legal Events

Date Code Title Description
FC Application refused